| P50 | author | Frederik B. Clausen | Q42327851 |
| | Morten Hanefeld Dziegiel | Q55100179 |
| | Mette Christiansen | Q59163926 |
| P2093 | author name string | K R Nielsen | |
| | R Steffensen | |
| | N Grunnet | |
| | K M Homburg | |
| | K Rieneck | |
| | U Sprogøe | |
| | G R Krog | |
| | J Baech | |
| | M A Jakobsen | |
| | M Rudby | |
| | R D Madsen | |
| | T R Jakobsen | |
| P2860 | cites work | Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 |
| | RhD haemolytic disease of the fetus and the newborn | Q33901403 |
| | Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience | Q34192088 |
| | From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges | Q34286705 |
| | Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008 | Q34306068 |
| | Recent advances in the prenatal interrogation of the human fetal genome | Q34312211 |
| | Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 |
| | Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program | Q34936608 |
| | Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD | Q35034936 |
| | Non-invasive antenatal RHD typing | Q36431820 |
| | Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 |
| | The safety of RhIG in the prevention of haemolytic disease of the newborn | Q36951785 |
| | Non-invasive prenatal diagnosis and determination of fetal Rh status | Q37077064 |
| | Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects | Q37351817 |
| | The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma | Q37934379 |
| | Uses of cell free fetal DNA in maternal circulation | Q38006298 |
| | Genomic analysis of fetal nucleic acids in maternal blood | Q38015501 |
| | Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status | Q38090127 |
| | Anti-D prophylaxis: past, present and future | Q38239704 |
| | Non-invasive prenatal determination of fetal sex: translating research into clinical practice | Q44982893 |
| | Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis | Q46172895 |
| | One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy | Q47683487 |
| | Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark. | Q50556010 |
| | An international reference reagent for the detection of RHD and SRY DNA in plasma. | Q51406742 |
| | Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. | Q53597278 |
| | Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. | Q54301772 |
| | Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. | Q54342228 |
| | The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Q54520641 |
| | Presence of fetal DNA in maternal plasma and serum | Q57075132 |
| P433 | issue | 10 | |
| P921 | main subject | Denmark | Q35 |
| | human pregnancy | Q11995 |
| | pregnant person | Q104720811 |
| P304 | page(s) | 1000-1005 | |
| P577 | publication date | 2014-06-13 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark | |
| P478 | volume | 34 | |